Compound ID | 1798

Update compound information

α-hemolysin inhibitor

Class: Alpha-hemolysin inhibitor

Spectrum of activity: Gram-positive
Details of activity: Antivirulence approach used against Staphylococcus aureus. Inhibitor of α-hemolysin
Combined with other compounds: Yes
Description: Synthetic compound. Received CARB-X funding
Institute where first reported: Helmholtz Centre for Infection Research GmbH, Braunschweig, Germany
Year first mentioned: 2020
Highest developmental phase: Preclinical
Development status: Active (as of 2022)
External links:
Citation: https://carb-x.org/carb-x-news/carb-x-is-funding-a-team-of-top-german-researchers-to-develop-a-drug-to-treat-staphylococcus-aureus-infections-and-prevent-exacerbation-of-life-threatening-pneumonia/

AntibioticDB is supported by GARDP.

If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.